E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/29/2012 in the Prospect News PIPE Daily.

Applied DNA wraps $2 million of $7.5 million stock, preferreds sale

Deal sells stock, preferreds along with warrants for 51,075,268 shares

By Devika Patel

Knoxville, Tenn., Nov. 29 - Applied DNA Sciences, Inc. arranged a $7.5 million private placement of stock and series A convertible preferred stock with Crede CG II, Ltd. on Nov. 28, according to an 8-K filed Thursday with the Securities and Exchange Commission. It settled the $2 million stock portion on Nov. 29.

The company sold 10,752,688 common shares at $0.186 apiece. The price per share is a 2.11% discount to the Nov. 27 closing share price of $0.19 and also was the consolidated closing bid price of the stock on the day prior to pricing, the company noted in the filing.

The investor also will buy 5,500 preferreds at $1,000 per preferred. The preferreds convert to common stock at a fixed conversion price of $0.186 (the price-per share of the stock sold in the placement) or a non-fixed conversion price, which will be equal to the consolidated closing bid price of the stock on the trading day preceding conversion.

Crede also received warrants, each exercisable at $0.2232, a 17.47% premium to the Nov. 27 closing price. The five-year series A warrants are exercisable for 10,752,688 shares; the five-year series B warrants are exercisable for 29,569,892 shares and the six-month series C warrants are exercisable for 10,752,688 shares.

Stony Brook, N.Y.-based Applied DNA Sciences provides patented DNA-based technologies to prevent and identify counterfeits.

Issuer:Applied DNA Sciences, Inc.
Issue:Common stock, series A convertible preferred stock
Amount:$7.5 million
Warrants:For 51,075,268 shares
Warrant expiration:Five years (for 40,322,580 shares), six months (for 10,752,688 shares)
Warrant strike price:$0.2232
Investor:Crede CG II, Ltd.
Pricing date:Nov. 28
Stock symbol:OTCBB: APDN
Stock price:$0.19 at close Nov. 27
Market capitalization:$132.42 million
Common shares
Amount:$2 million
Shares:10,752,688
Price:$0.186
Settlement date:Nov. 29
Preferreds
Amount:$5.5 million
Preferreds:5,500
Price:$1,000

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.